|
1
|
Atta HM: Reversibility and heritability of
liver fibrosis: Implications for research and therapy. World J
Gastroenterol. 21:5138–5148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kisseleva T and Brenner DA: Hepatic
stellate cells and the reversal of fibrosis. J Gastroenterol
Hepatol. 21 (Suppl 3):S84–S87. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gressner OA and Gressner AM: Connective
tissue growth factor: A fibrogenic master switch in fibrotic liver
diseases. Liver Int. 28:1065–1079. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Salazar-Montes AM, Hernández-Ortega LD,
Lucano-Landeros MS and Armendariz-Borunda J: New gene therapy
strategies for hepatic fibrosis. World J Gastroenterol.
21:3813–3825. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gonzalez-Rodriguez A and Valverde AM: RNA
interference as a therapeutic strategy for the treatment of liver
diseases. Curr Pharm Des. 21:4574–4586. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng K, Yang N and Mahato RI: TGF-beta1
gene silencing for treating liver fibrosis. Mol Pharm. 6:772–779.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Omar R, Yang J, Liu H, Davies NM and Gong
Y: Hepatic stellate cells in liver fibrosis and siRNA-based
therapy. Rev Physiol Biochem Pharmacol. 172:1–37. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Motoyama H, Ogawa S, Kubo A, Miwa S,
Nakayama J, Tagawa Y and Miyagawa S: In vitro reprogramming of
adult hepatocytes into insulin-producing cells without viral
vectors. Biochem Biophys Res Commun. 385:123–128. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou J, Shum KT, Burnett JC and Rossi JJ:
Nanoparticle-based delivery of RNAi therapeutics: Progress and
challenges. Pharmaceuticals (Basel). 6:85–107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Poilil Surendran SP, Thomas RG, Moon MJ
and Jeong YY: Nanoparticles for the treatment of liver fibrosis.
Int J Nanomedicine. 12:6997–7006. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li TT, Shen X, Chen Y, Zhang CC, Yan J,
Yang H, Wu CH, Zeng HJ and Liu YY: Polyetherimide-grafted
Fe3O4@SiO2 nanoparticles as
theranostic agents for simultaneous VEGF siRNA delivery and
magnetic resonance cell imaging. Int J Nanomedicine. 10:4279–4291.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shirazi AN, Paquin KL, Howlett NG, Mandal
D and Parang K: Cyclic peptide-capped gold nanoparticles for
enhanced siRNA delivery. Molecules. 19:13319–13331. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Zhao Q, Han N, Bai L, Li J, Liu J,
Che E, Hu L, Zhang Q, Jiang T and Wang S: Mesoporous silica
nanoparticles in drug delivery and biomedical applications.
Nanomedicine. 11:313–327. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reina G, Gismondi A, Carcione R, Nanni V,
Peruzzi C, Angjellari M, Chau NDQ, Canini A, Terranova ML and
Tamburri E: Oxidized and amino-functionalized nanodiamonds as
shuttle for delivery of plant secondary metabolites: Interplay
between chemical affinity and bioactivity. Appl Surface Sci.
470:744–754. 2019. View Article : Google Scholar
|
|
15
|
Getz T, Qin J, Medintz IL, Delehanty JB,
Susumu K, Dawson PE and Dawson G: Quantum dot-mediated delivery of
siRNA to inhibit sphingomyelinase activities in brain-derived
cells. J Neurochem. 139:872–885. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gupta AK and Gupta M: Synthesis and
surface engineering of iron oxide nanoparticles for biomedical
applications. Biomaterials. 26:3995–4021. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu W, He QG and Jiang CZ: Magnetic iron
oxide nanoparticles: Synthesis and surface functionalization
strategies. Nanoscale Res Lett. 3:397–415. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiao S, Castro R, Rodrigues J, Shi X and
Tomás H: PAMAM dendrimer/pDNA functionalized-magnetic iron oxide
nanoparticles for gene delivery. J Biomed Nanotechnol.
11:1370–1384. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Saeed M, Ren W and Wu A: Therapeutic
applications of iron oxide based nanoparticles in cancer: Basic
concepts and recent advances. Biomater Sci. 6:708–725. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li J, Zou S, Gao J, Liang J, Zhou H, Liang
L and Wu W: Block copolymer conjugated Au-coated
Fe3O4 nanoparticles as vectors for enhancing
colloidal stability and cellular uptake. J Nanobiotechnology.
15:562017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Friedman SL: Cytokines and fibrogenesis.
Semin Liver Dis. 19:129–140. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bataller R and Brenner DA: Liver fibrosis.
J Clin Invest. 115:209–218. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Elpek GÖ: Cellular and molecular
mechanisms in the pathogenesis of liver fibrosis: An update. World
J Gastroenterol. 20:7260–7276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Trautwein C, Friedman SL, Schuppan D and
Pinzani M: Hepatic fibrosis: Concept to treatment. J Hepatol. 62 (1
Suppl):S15–S24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang CY, Yuan WG, He P, Lei JH and Wang
CX: Liver fibrosis and hepatic stellate cells: Etiology,
pathological hallmarks and therapeutic targets. World J
Gastroenterol. 22:10512–10522. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schuppan D, Surabattula R and Wang XY:
Determinants of fibrosis progression and regression in NASH. J
Hepatol. 68:238–250. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lipson KE, Wong C, Teng Y and Spong S:
CTGF is a central mediator of tissue remodeling and fibrosis and
its inhibition can reverse the process of fibrosis. Fibrogenesis
Tissue Repair. 5 (Suppl 1):S242012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hao C, Xie Y, Peng M, Ma L, Zhou Y, Zhang
Y, Kang W, Wang J, Bai X, Wang P and Jia Z: Inhibition of
connective tissue growth factor suppresses hepatic stellate cell
activation in vitro and prevents liver fibrosis in vivo. Clin Exp
Med. 14:141–150. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li G, Xie Q, Shi Y, Li D, Zhang M, Jiang
S, Zhou H, Lu H and Jin Y: Inhibition of connective tissue growth
factor by siRNA prevents liver fibrosis in rats. J Gene Med.
8:889–900. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Taymouri S and Taheri A: Use of
nanotechnology in diagnosis and treatment of hepatic fibrosis: A
review. Curr Drug Deliv. 13:662–672. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Southern EM: Detection of specific
sequences among DNA fragments separated by gel electrophoresis. J
Mol Biol. 98:503–517. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu J and Zern MA: Hepatic stellate cells:
A target for the treatment of liver fibrosis. J Gastroenterol.
35:665–672. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gressner AM, Weiskirchen R, Breitkopf K
and Dooley S: Roles of TGF-beta in hepatic fibrosis. Front Biosci.
7:d793–d807. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang N, Dang S, Shi J, Wu F, Li M, Zhang
X, Li Y, Jia X and Zhai S: Caffeic acid phenethyl ester attenuates
liver fibrosis via inhibition of TGF-β1/Smad3 pathway and induction
of autophagy pathway. Biochem Biophys Res Commun. 486:22–28. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee UE and Friedman SL: Mechanisms of
hepatic fibrogenesis. Best Pract Res Clin Gastroenterol.
25:195–206. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang G and Brigstock DR: Regulation of
hepatic stellate cells by connective tissue growth factor. Front
Biosci (Landmark Ed). 17:2495–2507. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yuhua Z, Wanhua R, Chenggang S, Jun S,
Yanjun W and Chunqing Z: Disruption of connective tissue growth
factor by short hairpin RNA inhibits collagen synthesis and
extracellular matrix secretion in hepatic stellate cells. Liver
Int. 28:632–639. 2008. View Article : Google Scholar : PubMed/NCBI
|
